TLR2 ligand-synthetic long peptide conjugates effectively stimulate tumor-draining lymph node T cells of cervical cancer patients

Gijs G. Zom; Marij J. P. Welters; Nikki M. Loof; Renske Goedemans; Sinead Lougheed; Rob R. P. M. Valentijn; Maarten L. Zandvliet; Nico J. Meeuwenoord; Cornelis J. M. Melief; Tanja D. de Gruijl; Gijsbert A. Van der Marel; Dmitri V. Filippov; Ferry Ossendorp; Sjoerd H. Van der Burg

doi:10.18632/oncotarget.11512

TLR2 ligand-synthetic long peptide conjugates effectively stimulate tumor-draining lymph node T cells of cervical cancer patients

Gijs G. Zom
, Marij J. P. Welters
, Nikki M. Loof
, Renske Goedemans
, Sinead Lougheed
, Rob R. P. M. Valentijn
, Maarten L. Zandvliet
, Nico J. Meeuwenoord
, Cornelis J. M. Melief
, Tanja D. de Gruijl
, Gijsbert A. Van der Marel
, Dmitri V. Filippov
, Ferry Ossendorp
, Sjoerd H. Van der Burg

Research output: Contribution to journal › Article › Academic › peer-review

9 Downloads (Pure)

Original language	English
Pages (from-to)	67087-67100
Journal	Oncotarget
Volume	7
Issue number	41
DOIs	https://doi.org/10.18632/oncotarget.11512
Publication status	Published - 11 Oct 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Toll-like receptor ligand
conjugate
synthetic long peptide
cancer vaccine
cervical cancer

Access to Document

10.18632/oncotarget.11512

Tlr2-ligand-synthetic-long-peptide-conjugates-effectively-stimulate-tumor-draining-lymph-node-t-cells-of-cervical-cancer.pdfFinal published version, 2.08 MBLicence: Taverne

Cite this

Zom, G. G., Welters, M. J. P., Loof, N. M., Goedemans, R., Lougheed, S., Valentijn, R. R. P. M., Zandvliet, M. L., Meeuwenoord, N. J., Melief, C. J. M., de Gruijl, T. D., Van der Marel, G. A., Filippov, D. V., Ossendorp, F., & Van der Burg, S. H. (2016). TLR2 ligand-synthetic long peptide conjugates effectively stimulate tumor-draining lymph node T cells of cervical cancer patients. Oncotarget, 7(41), 67087-67100. https://doi.org/10.18632/oncotarget.11512

@article{b9d5ce8308ea4d80a0f4b25216673000,

title = "TLR2 ligand-synthetic long peptide conjugates effectively stimulate tumor-draining lymph node T cells of cervical cancer patients",

keywords = "Toll-like receptor ligand, conjugate, synthetic long peptide, cancer vaccine, cervical cancer",

author = "Zom, \{Gijs G.\} and Welters, \{Marij J. P.\} and Loof, \{Nikki M.\} and Renske Goedemans and Sinead Lougheed and Valentijn, \{Rob R. P. M.\} and Zandvliet, \{Maarten L.\} and Meeuwenoord, \{Nico J.\} and Melief, \{Cornelis J. M.\} and \{de Gruijl\}, \{Tanja D.\} and \{Van der Marel\}, \{Gijsbert A.\} and Filippov, \{Dmitri V.\} and Ferry Ossendorp and \{Van der Burg\}, \{Sjoerd H.\}",

year = "2016",

month = oct,

day = "11",

doi = "10.18632/oncotarget.11512",

language = "English",

volume = "7",

pages = "67087--67100",

journal = "Oncotarget",

issn = "1949-2553",

publisher = "Impact Journals LLC",

number = "41",

}

Zom, GG, Welters, MJP, Loof, NM, Goedemans, R, Lougheed, S, Valentijn, RRPM, Zandvliet, ML, Meeuwenoord, NJ, Melief, CJM, de Gruijl, TD, Van der Marel, GA, Filippov, DV, Ossendorp, F & Van der Burg, SH 2016, 'TLR2 ligand-synthetic long peptide conjugates effectively stimulate tumor-draining lymph node T cells of cervical cancer patients', Oncotarget, vol. 7, no. 41, pp. 67087-67100. https://doi.org/10.18632/oncotarget.11512

TY - JOUR

T1 - TLR2 ligand-synthetic long peptide conjugates effectively stimulate tumor-draining lymph node T cells of cervical cancer patients

AU - Zom, Gijs G.

AU - Welters, Marij J. P.

AU - Loof, Nikki M.

AU - Goedemans, Renske

AU - Lougheed, Sinead

AU - Valentijn, Rob R. P. M.

AU - Zandvliet, Maarten L.

AU - Meeuwenoord, Nico J.

AU - Melief, Cornelis J. M.

AU - de Gruijl, Tanja D.

AU - Van der Marel, Gijsbert A.

AU - Filippov, Dmitri V.

AU - Ossendorp, Ferry

AU - Van der Burg, Sjoerd H.

PY - 2016/10/11

Y1 - 2016/10/11

KW - Toll-like receptor ligand

KW - conjugate

KW - synthetic long peptide

KW - cancer vaccine

KW - cervical cancer

U2 - 10.18632/oncotarget.11512

DO - 10.18632/oncotarget.11512

M3 - Article

C2 - 27564262

SN - 1949-2553

VL - 7

SP - 67087

EP - 67100

JO - Oncotarget

JF - Oncotarget

IS - 41

ER -